(Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 7.78%7.81B | 11.11%4.66B | -7.44%11.53B | 0.24%10.25B | 10.57%7.24B | -0.53%4.19B | 35.25%12.46B | 25.56%10.22B | 17.50%6.55B | 30.74%4.21B |
Special items of operating revenue | ---- | ---- | -94.81%5.63M | -94.31%5.63M | -92.93%5.63M | -88.84%4.02M | -13.12%108.32M | 11.08%98.84M | 40.41%79.6M | 35.38%36M |
Operating income | 7.70%7.81B | 11.00%4.66B | -8.20%11.53B | -0.66%10.25B | 9.32%7.25B | -1.28%4.19B | 34.61%12.56B | 25.40%10.32B | 17.73%6.63B | 30.78%4.25B |
Operating expenses | -6.29%-6.48B | -9.05%-3.85B | 7.63%-9.7B | -0.28%-8.55B | -11.15%-6.1B | -0.24%-3.53B | -36.10%-10.5B | -25.82%-8.53B | -19.45%-5.48B | -34.46%-3.52B |
Gross profit | 15.15%1.33B | 21.39%806.12M | -11.11%1.84B | -5.15%1.7B | 0.58%1.15B | -8.65%664.07M | 27.51%2.07B | 23.42%1.8B | 10.16%1.15B | 15.44%726.95M |
Selling expenses | 10.02%-83.14M | -29.17%-44.09M | -8.41%-240.89M | -26.62%-151.18M | -39.55%-92.4M | 16.15%-34.14M | -9.03%-222.21M | -0.52%-119.39M | 14.99%-66.21M | 13.07%-40.71M |
Administrative expenses | 3.49%-153.17M | 7.01%-69.69M | 8.75%-360.64M | -6.01%-252.61M | 0.13%-158.7M | -1.46%-74.95M | -8.76%-395.2M | -2.20%-238.28M | 0.14%-158.91M | -2.41%-73.87M |
Research and development expenses | -13.84%-205.29M | -15.18%-95.21M | 12.75%-461.34M | 14.79%-290.17M | 3.25%-180.33M | 5.59%-82.66M | -27.31%-528.78M | -20.92%-340.52M | 0.71%-186.39M | -4.28%-87.55M |
Profit from asset sales | 92.03%1.43M | -65.26%87.82K | -4.49%1.56M | -32.15%1.14M | 14.69%743.24K | 58.45%252.83K | 2,498.01%1.63M | -65.37%1.69M | -80.88%648.07K | -95.05%159.56K |
Revaluation surplus | -37.43%16.63M | -76.05%1.53M | 120.56%47.76M | 115.31%36.66M | 130.75%26.57M | 386.06%6.39M | -705.67%-232.28M | -1,912.86%-239.52M | -380.60%-86.42M | 151.92%1.32M |
-Changes in the fair value of other assets | -37.43%16.63M | -76.05%1.53M | 120.56%47.76M | 115.31%36.66M | 130.75%26.57M | 386.06%6.39M | -705.67%-232.28M | -1,912.86%-239.52M | -380.60%-86.42M | 151.92%1.32M |
Impairment and provision | 26.88%-11.52M | -32.38%-19.81M | 86.16%-18.25M | 88.08%-16.52M | 79.29%-15.76M | 69.82%-14.96M | 83.85%-131.84M | 78.89%-138.6M | 87.86%-76.1M | -63.41%-49.58M |
-Other impairment is provision | 26.88%-11.52M | -32.38%-19.81M | 86.16%-18.25M | 88.08%-16.52M | 79.29%-15.76M | 69.82%-14.96M | 83.85%-131.84M | 78.89%-138.6M | 87.86%-76.1M | -63.41%-49.58M |
Operating interest expense | ---- | ---- | 99.18%-99.84K | 99.15%-99.84K | 99.04%-99.84K | 97.80%-99.22K | 43.82%-12.12M | 33.54%-11.71M | 5.54%-10.37M | 18.24%-4.51M |
Special items of operating profit | 134.24%188.68M | 260.18%121.38M | 292.90%194.56M | 93.31%123.27M | 75.34%80.55M | -3.56%33.7M | -92.74%49.52M | -89.34%63.77M | -91.80%45.94M | 235.51%34.94M |
Operating profit | 34.00%1.06B | 41.73%687.66M | 74.05%950.75M | 51.75%1.11B | 34.83%788.23M | -1.99%485.2M | 14.28%546.25M | 0.78%734.72M | 6.61%584.63M | 26.14%495.05M |
Financing cost | -29.85%21.1M | 58.61%12.86M | 8.97%45.51M | 51.19%42.05M | 1,261.13%30.08M | 236.03%8.11M | 181.72%41.77M | 188.32%27.81M | 109.54%2.21M | 4.91%-5.96M |
Special items of earning before tax | 37.45%3.69M | 44.70%2.51M | -71.44%6.82M | 23.81%3.17M | 31.47%2.68M | -2.20%1.73M | -28.49%23.88M | -86.07%2.56M | -65.63%2.04M | 271.92%1.77M |
Earning before tax | 31.67%1.08B | 42.01%703.03M | 63.93%1B | 51.64%1.16B | 39.42%821M | 0.85%495.04M | 32.94%611.9M | 6.87%765.09M | 10.86%588.87M | 26.94%490.87M |
Tax | -185.36%-161.3M | -7,685.19%-96.13M | -146.77%-14.06M | -605.92%-67.86M | -654.73%-56.52M | 140.33%1.27M | 211.55%30.06M | 130.00%13.41M | 56.73%-7.49M | -194.33%-3.14M |
After-tax profit from continuing operations | 23.11%919.7M | 23.25%606.9M | 73.99%971.62M | 51.53%1.07B | 39.11%747.06M | 7.91%492.42M | 46.31%558.43M | 5.69%709.39M | 4.51%537.03M | 17.00%456.32M |
After-tax profit from non-continuing business | ---- | ---- | -79.16%17.41M | -74.81%17.41M | -60.75%17.41M | -87.62%3.89M | 61.69%83.53M | --69.11M | --44.36M | --31.4M |
Earning after tax | 20.30%919.7M | 22.28%606.9M | 54.06%989.03M | 40.31%1.09B | 31.49%764.48M | 1.76%496.31M | 48.14%641.96M | 15.99%778.51M | 13.14%581.39M | 25.05%487.72M |
Minority profit | 38.87%14.35M | -29.03%7.51M | 79.55%-8M | 141.21%7.13M | 12,778.30%10.33M | 49.30%10.58M | -703.39%-39.09M | -952.52%-17.3M | -103.29%-81.48K | 305.35%7.08M |
Profit attributable to shareholders | 20.05%905.35M | 23.40%599.4M | 46.39%997.02M | 36.36%1.09B | 29.70%754.14M | 1.06%485.73M | 55.42%681.05M | 18.92%795.8M | 13.71%581.47M | 23.79%480.64M |
Basic earnings per share | 23.39%0.5334 | 46.39%0.8873 | 36.37%0.9658 | 1.08%0.4323 | 53.83%0.6061 | 17.29%0.7082 | 11.39%0.5175 | 18.71%0.4277 | ||
Diluted earnings per share | 23.39%0.5334 | 46.39%0.8873 | 36.37%0.9658 | 1.08%0.4323 | 53.83%0.6061 | 17.29%0.7082 | 11.39%0.5175 | 18.71%0.4277 | ||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Auditor | -- | -- | Shinnaganaka & Chung Certified Public Accountants (Special General Partnership) | -- | -- | -- | Shinnaganaka & Chung Certified Public Accountants (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data